Organogel Nanoparticles as a New Way to Improve Oral Bioavailability of Poorly Soluble Compounds
Sign Up to like & getrecommendations! Published in 2020 at "Pharmaceutical Research"
DOI: 10.1007/s11095-020-02808-w
Abstract: The aim of the study was to evaluate organogel nanoparticles as a lipophilic vehicle to increase the oral bioavailability of poorly soluble compounds. Efavirenz (EFV), a Biopharmaceutical Classification System (BCS) Class II, was used as… read more here.
Keywords: oral bioavailability; poorly soluble; bioavailability; bioavailability poorly ... See more keywords